跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,601 条关于
“IL-17C”
全部
5,601
临床试验
2,917
药物
1,264
机构
19
资讯
1,401
10个月前
UNION Therapeutics Publishes Biomarker Data Showing Orismilast's Multi-Pathway Anti-Inflammatory Effects in Psoriasis
去年
Spesolimab Shows Promise in Treating Pediatric Generalized Pustular Psoriasis
去年
Seven-Year US Safety Data Confirms Brodalumab's Stable Risk Profile in Psoriasis Treatment
去年
Bimzelx Approved by FDA as First IL-17A and IL-17F Inhibitor for Hidradenitis Suppurativa
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
12个月前
Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones
去年
Medicenna Secures Five New Patents for IL-2 and IL-4 Superkine Immunotherapies
2年前
Medicenna Presents Preclinical Data on IL-2 Super-Antagonist MDNA209 and Anti-PD1-IL-2 BiSKIT MDNA113
去年
FDA Approves UCB's Bimzelx (bimekizumab-bkzx) for Hidradenitis Suppurativa
8个月前
Turn Therapeutics Advances Phase 2 Atopic Dermatitis Trial with First-in-Class IL-36/IL-31 Inhibitor GX-03
第 1 页,共 141 页
上一页
下一页